APGE

NASDAQ · Biotechnology

Apogee Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$132.68

-0.01 (-0.01%)

As of Jun 25, 9:56 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 20 80%

Hold 5 20%

Sell 0 0%

Price Target

Analyst Price Target -23.4% upside

Low Target $78.76

Average Target $101.57

High Target $153.22

Current Price $132.68

Current
$132.68

Target
$101.57

$78.76 $101.57 avg $153.22

Scenario Analysis

Bear Case

$78.76

-40.6%

Low target

Base Case

$101.57

-23.4%

Avg target

Bull Case

$153.22

+15.5%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$95.32

39.2% from high

52-Week Low

$34.34

+286.4% from low

50-Day SMA

$73.88

+79.6% vs SMA

200-Day SMA

$52.13

+154.5% vs SMA

RSI (14)

48.1

Neutral

Target vs 52W High

$101.57

+6.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+5.9%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+192.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-8.7%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.6%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-36.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.2%